glp 1 and naion GLP-1 RAs NAION: No increased risk in large US study | Paramesh Shamanna posted on the topic Anterior ischemic optic neuropathy in
Description
The more meaningful question is not: Do patients regain weight after stopping GLP-1s? It is: How should we transition patients from pharmacologic support to long-term weight maintenance? Obesity is a chronic disease
A decrease in LAV was observed in the HFrEF population (WMD: -5.4 ml [95% CI: -8.8, -2.0]
Territory Foods is a healthy meal delivery service
Experts acknowledged an adverse effect noted by patients using glucagon-like peptide-1 receptor agonists.
